Search results for "microRNAs"

showing 10 items of 350 documents

Resveratrol initiates differentiation of mouse skeletal muscle-derived C2C12 myoblasts.

2012

Resveratrol is one of the most widely studied bio-active plant polyphenols. While its effect on endothelial blood vessel cells, cancer cells, inflammatory processes and neurodegenerative events is well documented, little is known about the implication of this phytophenol in differentiating processes, particularly in skeletal muscle cells. Here, we report the effects of resveratrol on mouse skeletal muscle-derived cells (C2C12) in either a nondifferentiated (myoblasts) or differentiated state (myotubes) by evaluating resveratrol uptake, cell proliferation, changes in cell shape, and the expression of genes encoding muscle-specific transcription factors or contractile proteins. Resveratrol: (…

Transcription GeneticCellular differentiationMyoblasts SkeletalMuscle Fibers SkeletalBiologyResveratrolMyosinsBiochemistryCell Linechemistry.chemical_compoundMiceStilbenesmedicineMyocyteAnimalsCell ShapeMyogeninCell ProliferationPharmacologyMyogenesisfood and beveragesSkeletal muscleCell DifferentiationMolecular biologyMicroRNAsmedicine.anatomical_structurechemistryResveratrolCancer cellC2C12Transcription FactorsBiochemical pharmacology
researchProduct

High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells.

2009

AIM: To analyze the relevance of the microRNA miR-196a for colorectal oncogenesis. METHODS: The impact of miR-196a on the restriction targets HoxA7, HoxB8, HoxC8 and HoxD8 was analyzed by reverse transcription polymerase chain reaction (RT-PCR) after transient transfection of SW480 cancer cells. The miR-196a transcription profile in colorectal cancer samples, mucosa samples and diverse cancer cell lines was quantified by RT-PCR. Transiently miR-196a-transfected colorectal cancer cells were used for diverse functional assays in vitro and for a xenograft lung metastasis model in vivo. RESULTS: HoxA7, HoxB8, HoxC8 and HoxD8 were restricted by miR-196a in a dose-dependent and gene-specific mann…

Transcription GeneticColorectal cancerColonTransplantation HeterologousMouse model of colorectal and intestinal cancerBiologymedicine.disease_causeMiceCell Line TumormicroRNAmedicineCell AdhesionAnimalsHumansProtein kinase BCell ProliferationAkt/PKB signaling pathwayGastroenterologyGeneral MedicineOriginal Articlesmedicine.diseaseReverse transcription polymerase chain reactionMicroRNAsPhenotypeCancer cellCancer researchCarcinogenesisColorectal NeoplasmsNeoplasm TransplantationSignal TransductionWorld journal of gastroenterology
researchProduct

An epistatic mini-circuitry between the transcription factors Snail and HNF4α controls liver stem cell and hepatocyte features exhorting opposite reg…

2011

Preservation of the epithelial state involves the stable repression of epithelial-to-mesenchymal transition program, whereas maintenance of the stem compartment requires the inhibition of differentiation processes. A simple and direct molecular mini-circuitry between master elements of these biological processes might provide the best device to keep balanced such complex phenomena. In this work, we show that in hepatic stem cell Snail, a transcriptional repressor of the hepatocyte differentiation master gene HNF4α, directly represses the expression of the epithelial microRNAs (miRs)-200c and-34a, which in turn target several stem cell genes. Notably, in differentiated hepatocytes HNF4α, p…

Transcription GeneticTranscription FactorCellular differentiationLiver Stem CellSnailMESH: Mice KnockoutMESH: HepatocytesMice0302 clinical medicineSnail; hnf4a; mir-200; mir-34a; stemness; hepatocyte differentiationHepatocyteMESH: AnimalsMice KnockoutHepatocyte differentiationmir-34a0303 health sciencesStemneStem CellsMicroRNACell DifferentiationMESH: Transcription FactorsCell biologySnailmir-200Hepatocyte Nuclear Factor 4Liver030220 oncology & carcinogenesisMiRs-200MESH: Hepatocyte Nuclear Factor 4Hepatocyte differentiation; HNF4a; MiR-34a; MiRs-200; Snail; Stemness; Animals; Cell Differentiation; Epithelial-Mesenchymal Transition; Hepatocyte Nuclear Factor 4; Hepatocytes; Liver; Mice; Mice Knockout; MicroRNAs; Snail Family Transcription Factors; Stem Cells; Transcription Factors; Transcription Genetic; Cell Biology; Molecular BiologyStem cellhnf4aMESH: Cell Differentiationhepatocyte differentiationEpithelial-Mesenchymal TransitionMESH: Stem Cells[SDV.BC]Life Sciences [q-bio]/Cellular BiologyBiologystemness03 medical and health sciencesStem Cellbiology.animalAnimals[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyEpithelial–mesenchymal transitionMESH: MiceMolecular BiologyTranscription factor030304 developmental biologyOriginal PaperAnimalMESH: Transcription GeneticSnail Family Transcription FactorCell BiologyMolecular biologyMicroRNAsMESH: Epithelial-Mesenchymal TransitionHepatocyte nuclear factor 4HepatocytesSnail Family Transcription FactorsMESH: MicroRNAsMESH: LiverTranscription FactorsCell Death & Differentiation
researchProduct

Hypoxia-inducible factor 1Α may regulate the commitment of mesenchymal stromal cells toward angio-osteogenesis by mirna-675-5P

2017

Abstract Background aims During bone formation, angiogenesis and osteogenesis are regulated by hypoxia, which is able to induce blood vessel formation, as well as recruit and differentiate human mesenchymal stromal cells (hMSCs). The molecular mechanisms involved in HIF-1α response and hMSC differentiation during bone formation are still unclear. This study aimed to investigate the synergistic role of hypoxia and hypoxia-mimetic microRNA miR-675-5p in angiogenesis response and osteo-chondroblast commitment of hMSCs. Methods By using a suitable in vitro cell model of hMSCs (maintained in hypoxia or normoxia), the role of HIF-1α and miR-675-5p in angiogenesis and osteogenesis coupling was inv…

Transcriptional ActivationVascular Endothelial Growth Factor A0301 basic medicineCancer ResearchAngiogenesisCellular differentiationImmunologyNeovascularization PhysiologicBiology03 medical and health scienceschemistry.chemical_compoundOsteogenesisMiR-675-5pmedicineHumansImmunology and AllergyHypoxiaCells Culturedbeta CateninGenetics (clinical)TransplantationOsteoblastsMesenchymal stromal cellMesenchymal stem cellWnt signaling pathwayCell DifferentiationMesenchymal Stem CellsOsteoblastCell BiologyHypoxia-Inducible Factor 1 alpha SubunitCell HypoxiaUp-RegulationCell biologyVascular endothelial growth factorMicroRNAsVascular endothelial growth factor A030104 developmental biologymedicine.anatomical_structureGene Expression RegulationOncologyHypoxia-inducible factorschemistryRegenerative medicineImmunologyOsteoblast commitmentCytotherapy
researchProduct

Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes

2015

Microalbuminuria provides the earliest clinical marker of diabetic nephropathy among patients with Type 1 diabetes, yet it lacks sensitivity and specificity for early histological manifestations of disease. In recent years microRNAs have emerged as potential mediators in the pathogenesis of diabetes complications, suggesting a possible role in the diagnosis of early stage disease. We used quantiative polymerase chain reaction (qPCR) to evaluate the expression profile of 723 unique microRNAs in the normoalbuminuric urine of patients who did not develop nephropathy (n = 10) relative to patients who subsequently developed microalbuminuria (n = 17). Eighteen microRNAs were strongly associated w…

Type 1 diabetesmicroalbuminuriabusiness.industrylcsh:Rlcsh:MedicineGeneral MedicineDiseaseBioinformaticsmedicine.diseaseArticlemicroRNAsNephropathyDiabetic nephropathyPathogenesisType 1 diabetesDiabetes mellitusmicroRNAmedicinegene ontologyprognostic modelMicroalbuminuriatarget analysisbusinessJournal of Clinical Medicine
researchProduct

Implicación de miRNAs en la toxicidad mediada por expansiones de repeticiones CTG en Distrofia Miotónica

2015

La distrofia miotónica tipo 1 (DM1) es una enfermedad neuromuscular causa por la expansión del triplete CTG en la región 3’ no codificante del gen DMPK. Las expansiones CUG en los transcritos DMPK mutantes forman una estructura en horquilla que secuestra diferentes factores nucleares provocando su falta de función parcial y la desregulación de la expresión génica a diferentes niveles. La mayoría de los defectos en la expresión génica se han reproducido en animales modelo para la enfermedad que expresan transcritos con repeticiones CUG de manera independiente a DMPK. En este trabajo nos propusimos analizar si un grupo de reguladores de la expresión génica está afectado por la toxicidad media…

UNESCO::CIENCIAS DE LA VIDA::Genética:CIENCIAS DE LA VIDA::Genética [UNESCO]:CIENCIAS DE LA VIDA::Biología humana ::Genética humana [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Biología humana ::Genética humanaDrosophilamodelos animalesDistrofia MiotónicaMuscleblindmicroRNAsMBNL1
researchProduct

Perfil genético, epigenético e inmunohistoquímico en los cánceres de mama esporádicos y hereditarios

2016

El cáncer de mama (CM) es una de las principales causas de muerte por cáncer en la mujer en todo el mundo. En la actualidad el CM se entiende como una enfermedad heterogénea que abarca una serie de entidades definidas por sus diferentes características biológicas y comportamientos clínicos. Todo ello ha llevado a la búsqueda de biomarcadores que, a nivel individual o en combinación con otros marcadores (perfiles), ofrezcan a una mayor precisión diagnóstica, en el comportamiento evolutivo y en la predicción de la respuesta terapéutica. El presente estudio considera como mecanismo etiopatogénico de referencia del CM las mutaciones en los genes supresores tumorales BRCA1 y BRCA2, característic…

UNESCO::CIENCIAS MÉDICAS ::Patología::CarcinogénesisinmunohistoquímicamamametilaciónUNESCO::CIENCIAS MÉDICAS ::Patología::Oncologíacnvcancer:CIENCIAS MÉDICAS ::Patología::Carcinogénesis [UNESCO]:CIENCIAS MÉDICAS ::Patología::Oncología [UNESCO]micrornas
researchProduct

Estudio del perfil de microRNAs circulantes en pacientes con déficit de alfa-1 antitripsina. Implicaciones diagnósticas, pronósticas y terapéuticas

2017

El déficit de alfa-1 antitripsina (DAAT) es una condición genética rara y hereditaria que conduce a la disminución de los niveles circulantes de alfa-1 antitripsina, aumentando significativamente el riesgo de padecer enfermedad pulmonar y hepática grave, en niños y adultos. Esta condición tiene una gran variabilidad, tanto genética como clínica, lo que dificulta su pronóstico. Los microRNAs son unas pequeñas moléculas alrededor de 22nt cuya función es la regulación de la expresión génica. Además, estas moléculas tienen gran potencial como biomarcadores por su localización en fluidos corporales, como la sangre, provenientes de órganos altamente vascularizados, incluyendo pulmones e hígado; s…

UNESCO::CIENCIAS MÉDICASmicroRNAs circulantes:CIENCIAS MÉDICAS [UNESCO]microRNAsdéficit de alfa-1 antitripsinaponóstico
researchProduct

Caracterización molecular del melanoma maligno mediante una aproximación genética y epigenética

2019

El melanoma es un tumor procedente de los melanocitos cuya incidencia ha ido en ascenso en las últimas décadas. La clasificación clásica del melanoma establece cuatro subtipos principales: melanoma de extensión superficial, melanoma nodular, léntigo maligno melanoma, y melanoma lentiginoso acral. Esta clasificación se basa principalmente en la presentación clínica e histopatológica, y el patrón de crecimiento del melanoma; sin embargo, su utilidad es limitada ya que carece de valor pronóstico. El reciente desarrollo de nuevas tecnologías de secuenciación como la secuenciación masiva o next-generation sequencing (NGS), ha permitido realizar un cribado exhaustivo de las alteraciones molecular…

alteraciones epigenéticasUNESCO::CIENCIAS DE LA VIDA::Biología molecularmetilaciónmutacionesmelanomasecuenciación masiva:CIENCIAS MÉDICAS ::Otras especialidades médicas [UNESCO]:CIENCIAS DE LA VIDA::Biología molecular [UNESCO]biología molecularUNESCO::CIENCIAS MÉDICAS ::Otras especialidades médicasmicroRNAs
researchProduct

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy

2021

Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by expansion of unstable CTG repeats in a non-coding region of the DMPK gene. CUG expansions in mutant DMPK transcripts sequester MBNL1 proteins in ribonuclear foci. Depletion of this protein is a primary contributor to disease symptoms such as muscle weakness and atrophy and myotonia, yet upregulation of endogenous MBNL1 levels may compensate for this sequestration. Having previously demonstrated that antisense oligonucleotides against miR-218 boost MBNL1 expression and rescue phenotypes in disease models, here we provide preclinical characterization of an antagomiR-218 molecule using the HSALR mouse model and patient-d…

antisense oligonucleotidetissue distributionRM1-950BiologyMyotonic dystrophyTranscriptomechemistry.chemical_compoundalternative splicingtranscriptomicsAtrophyDrug DiscoverymicroRNAmedicineMBNL1AntagomirCTG repeat expansionstherapeutic gene modulationCTG repeat expansions MBNL1 protein alternative splicing antisense oligonucleotide microRNAs myotonic dystrophy therapeutic gene modulation tissue distribution transcriptomicsmyotonic dystrophyMyogenesisMyotoniamedicine.diseasemicroRNAschemistryCancer researchMolecular MedicineOriginal ArticleTherapeutics. PharmacologyMBNL1 protein
researchProduct